Biocon — Fact Sheet (December 2017)

5 slides from Biocon's fact sheet, December 2017

Slide 1: Biocon Group Fact Sheet December 2017
BIOCON GROUP FACT SHEET December - 2017
Slide 2: Biocon Limited (Consolidated) Balance Sheet
BIOCON LIMITED (CONSOLIDATED) BALANCE SHEET (Rs Cr) December 31, 2017 March 31, 2017 ASSETS Non-current assets (a) Property, plant and equipment 3,498 3,553 (b) Capital work-in-progress 711 533 (c) Investment property 1 1 (d) Goodwill 26 26 (e) Other intangible assets 43 46 (f) Intangible assets und
Slide 3: Profit & Loss Statement 9M FY18 vs 9M FY17
BIOCON LIMITED (CONSOLIDATED) PROFIT & LOSS STATEMENT (Rs. Crores) 9M 9M Variance Particulars FY 18 FY 17 INCOME Small molecules 1,082 1,246 -13% Biologics 529 539 -2% Branded formulations 462 418 11% Research services 1,014 910 11% Inter-segment (127) (122) 5% Revenue from operations # 2,960 2,991
Slide 4: Profit & Loss Statement Q3 FY18 vs Q3 FY17
BIOCON LIMITED (CONSOLIDATED) PROFIT & LOSS STATEMENT (Rs. Crores) Q3 Q3 Variance Particulars FY 18 FY 17 INCOME Small molecules 369 407 -9% Biologics 190 222 -15% Branded formulations 156 123 27% Research services 388 332 17% Inter-segment (45) (40) 10% Revenue from operations # 1,058 1,044 1% Othe
Slide 5: Profit & Loss Statement Q3 FY18 vs Q2 FY18
BIOCON LIMITED (CONSOLIDATED) PROFIT & LOSS STATEMENT (Rs. Crores) Q3 Q2 Particulars Variance FY 18 FY 18 INCOME Small molecules 369 351 5% Biologics 190 156 22% Branded formulations 156 176 -11% Research services 388 335 16% Inter-segment (45) (49) -9% Revenue from operations # 1,058 969 9% Other i